Clinical Trials Directory

Trials / Completed

CompletedNCT05606120

H-35 CL TRAUMA Cemented Femoral Stem

A Post-market Study Evaluating Clinical and Radiographic Early Outcomes of Hip Arthroplasty With CL TRAUMA Cemented Femoral Stem

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
Limacorporate S.p.a · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study design: monocentric, retrospective, observational and post-market clinical study. Purpose: To demonstrate the safety and performance of CL TRAUMA femoral stem. The eligible study population is represented by the entire population that underwent a hip replacement with CL TRAUMA femoral stem from 2017 to 2023 at Azienda Ospedaliera di Padova (IT) in accordance with the indication for use of the product.

Conditions

Interventions

TypeNameDescription
DEVICECL TRAUMA femoral stemHip arthroplasty according to the instruction for use.

Timeline

Start date
2022-12-01
Primary completion
2025-01-23
Completion
2025-09-17
First posted
2022-11-04
Last updated
2026-01-15

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05606120. Inclusion in this directory is not an endorsement.

H-35 CL TRAUMA Cemented Femoral Stem (NCT05606120) · Clinical Trials Directory